Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.biopha.2021.111956 http://scihub22266oqcxt.onion/10.1016/j.biopha.2021.111956 34332377!8313489!34332377     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 263.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biomed+Pharmacother 2021 ; 142 (ä): 111956 Nephropedia Template TP {{tp|p=34332377|t=2021. A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status |pdf=|usr=}}{{34332377}} gab.com Text A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status JO: Biomed Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=34332377 #FOAvip Novel coronavirus 2019 (COVID-19) is a zoonosis that revised the global economic and societal progress since early 2020. The SARS-CoV-2 has been recognized as the responsible pathogen for COVID-19 with high infection and mortality rate potential. It has spread in 192 countries and infected about 1.5% of the world population, and still, a proper therapeutic approach is not unveiled. COVID-19 indication starts with fever to shortness of breathing, leading to ICU admission with the ventilation support in severe conditions. Besides the symptomatic mainstay clinical therapeutic approach, only Remdesivir has been approved by the FDA. Several pharmaceutical companies claimed different vaccines with exceptionally high efficacy (90-95%) against COVID-19; how long these vaccines can protect and long-term safety with the new variants are unpredictable. After the worldwide spread of the COVID-19 pandemic, numerous clinical trials with different phases are being performed to find the most appropriate solution to this condition. Some of these trials with old FDA-approved drugs showed promising results. In this review, we have precisely compiled the efforts to curb the disease and discussed the clinical findings of Ivermectin, Doxycycline, Vitamin-D, Vitamin-C, Zinc, and cannabidiol and their combinations. Additionally, the correlation of these molecules on the prophylactic and diseased ministration against COVID-19 has been explored. Twit Text FOAVip A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status ????Biomed Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=34332377 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34332377 #FOAvip English Wikipedia <ref>{{Cite pmid|34332377}}</ref> A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status #MMPMID34332377 Chowdhury A; Sajid M; Jahan N; Adelusi TI; Maitra P; Yin G; Wu X; Gao Y; Wang S Biomed Pharmacother 2021[Oct]; 142 (ä): 111956 PMID34332377show ga Novel coronavirus 2019 (COVID-19) is a zoonosis that revised the global economic and societal progress since early 2020. The SARS-CoV-2 has been recognized as the responsible pathogen for COVID-19 with high infection and mortality rate potential. It has spread in 192 countries and infected about 1.5% of the world population, and still, a proper therapeutic approach is not unveiled. COVID-19 indication starts with fever to shortness of breathing, leading to ICU admission with the ventilation support in severe conditions. Besides the symptomatic mainstay clinical therapeutic approach, only Remdesivir has been approved by the FDA. Several pharmaceutical companies claimed different vaccines with exceptionally high efficacy (90-95%) against COVID-19; how long these vaccines can protect and long-term safety with the new variants are unpredictable. After the worldwide spread of the COVID-19 pandemic, numerous clinical trials with different phases are being performed to find the most appropriate solution to this condition. Some of these trials with old FDA-approved drugs showed promising results. In this review, we have precisely compiled the efforts to curb the disease and discussed the clinical findings of Ivermectin, Doxycycline, Vitamin-D, Vitamin-C, Zinc, and cannabidiol and their combinations. Additionally, the correlation of these molecules on the prophylactic and diseased ministration against COVID-19 has been explored. |*COVID-19 Drug Treatment[MESH] |*SARS-CoV-2/drug effects/isolation & purification[MESH] |Antiviral Agents/pharmacology[MESH] |Ascorbic Acid/pharmacology[MESH] |COVID-19/epidemiology/prevention & control[MESH] |Cannabidiol/*pharmacology[MESH] |Dietary Supplements[MESH] |Doxycycline/pharmacology[MESH] |Drug Repositioning/methods[MESH] |Drug Therapy, Combination/methods[MESH] |Humans[MESH] |Ivermectin[MESH] |Treatment Outcome[MESH] |Vitamin D/pharmacology[MESH]A secondary approach with conventional medicines and supplements to re(epmc).pdf DeepDyve Pubget Overpricing